<DOC>
	<DOCNO>NCT02829177</DOCNO>
	<brief_summary>The objective determine lower serum uric acid mean allopurinol course kidney disease may effective prevent improve albuminuria renal function Type 1 Diabetic patient . The study double blind , randomise , placebo-controlled cross-over clinical trial .</brief_summary>
	<brief_title>Microalbuminuria Allopurinol Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Albuminuria ( ≥30 mg/g ) Uric Acid ≥ 0,265 mmol/l GFR ( glomerular filtration rate ) &gt; 40 ml/min/1.73m2 History gout xanthinuria indication uric acid lower therapy cancer chemotherapy . Recurrent renal calculus . Current use azathioprine , 6mercaptopurine , didanosine , tamoxifen , amoxicillin/ampicillin , drug interact allopurinol . Known allergy xanthineoxidase inhibitor . Renal transplant . Nondiabetic kidney disease . Home , 24h og clinical BP &gt; 180 Diastolic BP &gt; 130 mmHg screening . Cancer treatment within two year screen . History hepatitis B C. History acquire immune deficiency syndrome human immunodeficiency virus ( HIV ) infection . History alcohol drug abuse . Breastfeeding pregnancy unwillingness contraception throughout trial . Poor mental function reason expect patient difficulty comply requirement study . Serious preexist medical problem diabetes , e.g . congestive heart failure , pulmonary insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Diabetic nephropathy</keyword>
	<keyword>Albuminuria</keyword>
	<keyword>Allopurinol</keyword>
</DOC>